Scarica l'app Stockscreener
6.44
5.40%
0.33
Dopo l'orario di chiusura:
6.33
-0.11
-1.71%
Aclarion Inc Borsa (ACON) Ultime notizie
Growth Value: Can GCT Semiconductor Holding Inc stock weather global recessionJuly 2025 Trends & AI Powered Market Entry Ideas - moha.gov.vn
What drives Aclarion Inc stock priceReal Estate Investment Trusts & These 3 Stocks Could Change Your Portfolio - earlytimes.in
Aclarion shares move higher after Nociscan highlighted in spine surgery journal - MSN
Aclarion (ACON) Price Target Increased by 15.00% to 23.46 - Nasdaq
Can Aclarion Inc. Equity Warrant stock maintain growth trajectory2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Aclarion Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Will Aclarion Inc. stock deliver better than expected guidance2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Aclarion’s Nociscan featured in special pain issue of spine journal By Investing.com - Investing.com Nigeria
Is Aclarion Inc. (IT20) stock vulnerable to rate hikes2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
How Aclarion Inc. (IT20) stock gains from tech spendingMarket Performance Recap & Weekly Stock Performance Updates - Newser
Why Aclarion Inc. (IT20) stock stays resilientJuly 2025 Decliners & Target Return Focused Picks - Newser
How sustainable is Aclarion Inc. Equity Warrant stock dividend payout2025 Market Trends & Detailed Earnings Play Alerts - Newser
Aclarion, Inc. Stock (ACON) Opinions on Nociscan Technology Publication - Quiver Quantitative
Aclarion stock rises after feature in special pain issue of spine journal By Investing.com - Investing.com South Africa
Aclarion stock rises after feature in special pain issue of spine journal - Investing.com Canada
Aclarion’s Nociscan featured in special pain issue of spine journal - Investing.com
Aclarion announces publication of Nociscan article in pain issue of IJSS - TipRanks
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) - The Manila Times
Aclarion's Nociscan Featured in International Journal of Spine Surgery's Special Pain Issue, Highlighting Advances in Chronic Low Back Pain Diagnosis - Quiver Quantitative
Aclarion (Nasdaq: ACON) Nociscan case study guides targeted spine surgery - Stock Titan
Can Aclarion Inc. (IT20) stock sustain double digit ROEJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser
Is Aclarion Inc. (IT20) stock suitable for passive index fundsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser
Will Aclarion Inc. (IT20) stock sustain uptrend momentumQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Will Aclarion Inc. stock remain a Wall Street favoriteIPO Watch & Target Return Focused Stock Picks - Newser
Aug Intraday: Will QRAFT AI Enhanced U.S. Large Cap stock return to pre crash levelsJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ
Will Aclarion Inc. Equity Warrant stock reach Wall Street targets2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
How Aclarion Inc. stock performs in high volatility marketsTrade Exit Report & Advanced Swing Trade Entry Plans - Newser
Will Aclarion Inc. (IT20) stock outperform energy sector in 20252025 Volatility Report & AI Powered Market Trend Analysis - Newser
Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S - marketscreener.com
Aclarion, Inc. (ACON) 15.7% in Intraday Trading: Appointment of Commercial Director Drives Interest - Stocks Telegraph
Aclarion appoints Jason Brosniak as commercial director, Eastern U.S. - TipRanks
Press Release: Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - 富途牛牛
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - The Globe and Mail
Is Aclarion's Debt-Free Position The Backbone Of Its Next Phase Of Expansion? - RTTNews
2 innovative micro-cap stocks for 2026 - MSN
2 innovative micro-cap stocks for 2026 | 2025-12-01 | Investing News - Stockhouse
Is Aclarion Inc Equity Warrant a good long term investmentEarnings Forecast Updates & Affordable Growth Investments - earlytimes.in
Momentum Shift: Why Aclarion Inc. stock appeals to dividend seekersQuarterly Risk Review & Precise Buy Zone Identification - moha.gov.vn
Can Aclarion Inc. stock hit record highs againInflation Watch & Fast Moving Market Watchlists - moha.gov.vn
What margin trends mean for Aclarion Inc. stockMarket Activity Summary & Free Long-Term Investment Growth Plans - BỘ NỘI VỤ
Aclarion loss widens, but balance sheet remains strong - BizWest
Is Aclarion Inc a good long term investmentLarge Cap Stability Picks & Access Our Free Weekly Investment Letter - earlytimes.in
Critical Review: Aclarion (ACON) vs. The Competition - Defense World
Aclarion Inc. (ACON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Aclarion Inc. (IT20) stock stays on buy listsPortfolio Growth Summary & Smart Money Movement Tracker - newser.com
Is Aclarion Inc. Equity Warrant stock trading near support levels2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Positive Outlook on Aclarion, Inc. Driven by Revenue Growth and Strategic Investments - TipRanks
Ascendiant Capital Maintains Aclarion (ACON) Buy Recommendation - Nasdaq
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Aclarion (ACON) Sees Price Target Boost by Ascendiant Capital | - GuruFocus
How interest rate cuts could boost Aclarion Inc. stockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
1.32%
6.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):